1. Home
  2. CLNN vs GIFT Comparison

CLNN vs GIFT Comparison

Compare CLNN & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • GIFT
  • Stock Information
  • Founded
  • CLNN 2012
  • GIFT 1999
  • Country
  • CLNN United States
  • GIFT United States
  • Employees
  • CLNN N/A
  • GIFT N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • GIFT Catalog/Specialty Distribution
  • Sector
  • CLNN Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • CLNN Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • CLNN 43.0M
  • GIFT 37.1M
  • IPO Year
  • CLNN N/A
  • GIFT N/A
  • Fundamental
  • Price
  • CLNN $4.40
  • GIFT $1.08
  • Analyst Decision
  • CLNN Strong Buy
  • GIFT
  • Analyst Count
  • CLNN 4
  • GIFT 0
  • Target Price
  • CLNN $55.25
  • GIFT N/A
  • AVG Volume (30 Days)
  • CLNN 114.1K
  • GIFT 29.4K
  • Earning Date
  • CLNN 11-13-2024
  • GIFT 02-15-2025
  • Dividend Yield
  • CLNN N/A
  • GIFT N/A
  • EPS Growth
  • CLNN N/A
  • GIFT N/A
  • EPS
  • CLNN N/A
  • GIFT N/A
  • Revenue
  • CLNN $421,000.00
  • GIFT $86,439,146.00
  • Revenue This Year
  • CLNN N/A
  • GIFT N/A
  • Revenue Next Year
  • CLNN N/A
  • GIFT N/A
  • P/E Ratio
  • CLNN N/A
  • GIFT N/A
  • Revenue Growth
  • CLNN N/A
  • GIFT N/A
  • 52 Week Low
  • CLNN $3.82
  • GIFT $0.50
  • 52 Week High
  • CLNN $11.00
  • GIFT $4.65
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 45.63
  • GIFT N/A
  • Support Level
  • CLNN $4.04
  • GIFT N/A
  • Resistance Level
  • CLNN $5.47
  • GIFT N/A
  • Average True Range (ATR)
  • CLNN 0.47
  • GIFT 0.00
  • MACD
  • CLNN 0.02
  • GIFT 0.00
  • Stochastic Oscillator
  • CLNN 29.61
  • GIFT 0.00

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: